section 8
on 20 Mar 2020
Last Applicant/ Owned by
10 Union Square East, Suite 5B
New York
NY
10003
Serial Number
85603931 filed on 20th Apr 2012
Registration Number
4385102 registered on 13th Aug 2013
Filing Basis
1. intent to use
2. use application currently
Disclaimer
"THYROID CANCER CARE"
The mark consists of three concentric partial circles forming the letters "CCC" overlapped by the letter "T", combined with the wording "THYROID CANCER CARE COLLABORATIVE". Fundraising services, namely, raising funds for cancer research, prevention and treatment Color is not claimed as a feature of the mark. Providing information to researchers, doctors and patients in the field of cancer preveRead More
Fundraising services, namely, raising funds for cancer research, prevention and treatment
14th Dec 2011
14th Dec 2011
Medical and scientific research in the field of cancer treatment and diagnosis; providing laboratory research services in the field of oncology; providing medical research and scientific research information in the field of oncology via the Internet
14th Dec 2011
14th Dec 2011
Providing information to researchers, doctors and patients in the field of cancer prevention, diagnosis, treatment, recovery and survival
14th Dec 2011
14th Dec 2011
No 85603931
No Service Mark
No 15104/2
No
No
No
No
No
No
No
No
The mark consists of three concentric partial circles forming the letters "CCC" overlapped by the letter "T", combined with the wording "THYROID CANCER CARE COLLABORATIVE".
| Status Date | Action Taken |
|---|---|
| 20th Mar 2020 | CANCELLED SEC. 8 (6-YR) |
| 13th Aug 2018 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 13th Aug 2013 | REGISTERED-PRINCIPAL REGISTER |
| 09th Jul 2013 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 06th Jul 2013 | LAW OFFICE REGISTRATION REVIEW COMPLETED |
| 30th Jun 2013 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 26th Jun 2013 | STATEMENT OF USE PROCESSING COMPLETE |
| 20th Jun 2013 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 23rd May 2013 | USE AMENDMENT FILED |
| 23rd May 2013 | TEAS STATEMENT OF USE RECEIVED |
